Sergio Roa

7PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 03, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy.

Marcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor

|Mar 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay

|Feb 28, 2023
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Javier Melchor, Marcos Garcia-Lacarte, Sara C Grijalba

|Jul 18, 2022
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice.

Shanzhi Wang, Kyeryoung Lee, Stephen Gray

|Apr 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.

Marién Pascual, María Mena-Varas, Eloy Francisco Robles

|May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.

Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal

Pageof 2

Frequent Collaborators

3 joint publications

Jose Angel Martinez-Climent

3 joint publications

Juan José Lasarte

2 joint publications

Javier Melchor Sánchez

2 joint publications

Adrián Arnaiz-Leché